This map shows the geographic impact of B Angelkort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Angelkort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Angelkort more than expected).
This network shows the impact of papers produced by B Angelkort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Angelkort. The network helps show where B Angelkort may publish in the future.
Co-authorship network of co-authors of B Angelkort
This figure shows the co-authorship network connecting the top 25 collaborators of B Angelkort.
A scholar is included among the top collaborators of B Angelkort based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with B Angelkort. B Angelkort is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Lawall, Holger & B Angelkort. (1999). Correlation between rheological parameters and erythrocyte velocity in nailfold capillaries in patients with diabetes mellitus.. PubMed. 20(1). 41–7.14 indexed citations
8.
AGARDH, C.‐D., Juan García‐Puig, B Charbonnel, B Angelkort, & Anthony Barnett. (1996). Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine.. PubMed. 10(3). 185–92.109 indexed citations
Angelkort, B, et al.. (1990). [Arterial hypertension and hemorheology: the effects of triamterene and hydrochlorothiazide].. PubMed. 85(7). 425–8.3 indexed citations
Angelkort, B. (1981). Significance of antithrombotic effect in drug therapy of the chronic arterial occlusive disease.. PubMed. 11 Suppl 1. 215–21.2 indexed citations
14.
Angelkort, B. (1979). [Thrombocytic function, plasmatic blood coagulation and fibrinolysis in chronic arterial occlusive disease. Study with pentoxifilline].. PubMed. 30(34). 1239–43.22 indexed citations
15.
Angelkort, B, et al.. (1978). [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 73(21). 791–7.8 indexed citations
Angelkort, B, et al.. (1974). [Characteristic standard values for the kinetics of thrombocyte aggregation in platelet-containing plasma].. PubMed. 80. 1436–9.1 indexed citations
Angelkort, B, et al.. (1972). [Function, aggregation tendency and adhesiveness of thrombocytes in comparison with blood viscosity in Von Willebrand's syndrome and uremia].. PubMed. 23(48). 1808–10.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.